Devonian Health Group (TSXV:GSD) ROE % Adjusted to Book Value : 16.46% (As of Jul. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group ROE % Adjusted to Book Value?

Devonian Health Group's ROE % for the quarter that ended in Jul. 2024 was 31.10%. Devonian Health Group's PB Ratio for the quarter that ended in Jul. 2024 was 1.89. Devonian Health Group's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 was 16.46%.

Devonian Health Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Devonian Health Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group ROE % Adjusted to Book Value Chart

Devonian Health Group Annual Data

Trend

Jun15

Jun16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-30.84

-6.60

-7.98

-10.84

-4.51

Devonian Health Group Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-8.84	-8.92	-21.32	-4.63	16.46

Competitive Comparison of Devonian Health Group's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Devonian Health Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devonian Health Group's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's ROE % Adjusted to Book Value falls into.

Devonian Health Group ROE % Adjusted to Book Value Calculation

Devonian Health Group's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-8.53%	/	1.89
	=	-4.51%

Devonian Health Group's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	31.10%	/	1.89
	=	16.46%

Devonian Health Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

DVHGF:USA

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines